Genome Therapeutics Ltd
Private Limited Company · London
ActiveUnited KingdomIncorporated 2020Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 100 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 100 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 52
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2510_12392992_20250630
- Source archive
- Accounts_Monthly_Data-October2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 97 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2024-06-30
IXBRL · 97 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-07-01 to 2024-06-30
- Extraction status
- complete
- Numeric facts
- 53
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3500_12392992_20240630
- Source archive
- Accounts_Monthly_Data-January2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-06-30
IXBRL · 121 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2023-06-30
IXBRL · 121 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2022-07-01 to 2023-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 60
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1666_12392992_20230630
- Source archive
- Accounts_Monthly_Data-January2024.zip
Accounts to 2022-06-30
IXBRL · 118 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2022-06-30
IXBRL · 118 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2021-07-01 to 2022-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 63
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0003_12392992_20220630
- Source archive
- Accounts_Monthly_Data-February2023.zip
Accounts to 2021-06-30
IXBRL · 57 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2021-06-30
IXBRL · 57 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-08 to 2021-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0095_12392992_20210630
- Source archive
- Accounts_Monthly_Data-October2021.zip
Registered details
12392992- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2020-01-08
- Jurisdiction
- —
- Registered office
- REGENT HOUSE, 316 BEULAH HILL, LONDON, SE19 3HF, UNITED KINGDOM
Classification
1 SIC codes23006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2025-10-20
USD 10,500,006 raised
USD 51,713,186 estimated post-money
2025-08-08
USD 10,551,022 raised
USD 47,476,830 estimated post-money
Research and innovation
0 matched grantsNo matched UKRI or Innovate UK awards.